Revenue
114 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 114440000 USD Source
Annual consolidated revenue for 2025: about USD 427.5M, using the latest reported figures. The previous period, 2024, was about USD 305.5M.
114 million USD
2026 Q2 · USD
-15.25%
2026 Q2 · %
-29 million USD
2026 Q2 · USD
-39.1 million USD
2026 Q2 · USD
60317000 USD
100000000 USD
29803164 shares
3.81% · 1.1 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
454 million USD
2025-07-01 – 2026-06-30
-106 million USD
2025-07-01 – 2026-06-30
-48.7 million USD
2025-07-01 – 2026-06-30
27.1 million USD
2025-07-01 – 2026-06-30
-75.8 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-03.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 305.45 million
–
Current period
USD 427.54 million
–
427539000 − 305450000 = 122089000 USD
305450000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source427539000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 52.29 million
–
Current period
−USD 21.02 million
–
-21021000 − -52286000 = 31265000 USD
-52286000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-21021000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 28.5 million
–
Current period
USD 33.28 million
–
33279000 − -28496000 = 61775000 USD
-28496000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source33279000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 5.49 million
–
Current period
USD 19.02 million
–
19017000 − 5491000 = 13526000 USD
5491000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source19017000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | 133341000 | 162004000 Derived | -28663000 | -4763000 Derived | -23900000 | -26867000 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 196174000 | 226587000 Derived | -30413000 | -709000 Derived | -29704000 | -30651000 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 179322000 | 421316000 Derived | -241994000 | -654000 Derived | -241340000 | -117222000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 212195000 | 658344000 Derived | -446149000 | -200759000 Derived | -245390000 | -199834000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 234694000 | 902346000 Derived | -667652000 | -118672000 Derived | -548980000 | -326311000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 202566000 | 383162000 Derived | -180596000 | -4829000 Derived | -175767000 | -185397000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 305450000 | 328663000 Derived | -23213000 | 29073000 Derived | -52286000 | -33987000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 427539000 | 440616000 Derived | -13077000 | 7944000 Derived | -21021000 | 14262000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Revenue | 133341000 |
|
| 2019 | Revenue | 196174000 |
|
| 2020 | Revenue | 179322000 |
|
| 2021 | Revenue | 212195000 |
|
| 2022 | Revenue | 234694000 |
|
| 2023 | Revenue | 202566000 |
|
| 2024 | Revenue | 305450000 |
|
| 2025 | Revenue | 427539000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | 47.1% |
|
| 2020 | Year over year | -8.6% |
|
| 2021 | Year over year | 18.3% |
|
| 2022 | Year over year | 10.6% |
|
| 2023 | Year over year | -13.7% |
|
| 2024 | Year over year | 50.8% |
|
| 2025 | Year over year | 40% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Operating margin | -21.5% |
|
| 2019 | Operating margin | -15.5% |
|
| 2020 | Operating margin | -134.9% |
|
| 2021 | Operating margin | -210.3% |
|
| 2022 | Operating margin | -284.5% |
|
| 2023 | Operating margin | -89.2% |
|
| 2024 | Operating margin | -7.6% |
|
| 2025 | Operating margin | -3.1% |
|
| 2018 | Net margin | -17.9% |
|
| 2019 | Net margin | -15.1% |
|
| 2020 | Net margin | -134.6% |
|
| 2021 | Net margin | -115.6% |
|
| 2022 | Net margin | -233.9% |
|
| 2023 | Net margin | -86.8% |
|
| 2024 | Net margin | -17.1% |
|
| 2025 | Net margin | -4.9% |
|
| 2018 | Free cash flow margin | -20.1% |
|
| 2019 | Free cash flow margin | -15.6% |
|
| 2020 | Free cash flow margin | -65.4% |
|
| 2021 | Free cash flow margin | -94.2% |
|
| 2022 | Free cash flow margin | -139% |
|
| 2023 | Free cash flow margin | -91.5% |
|
| 2024 | Free cash flow margin | -11.1% |
|
| 2025 | Free cash flow margin | 3.3% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Operating cash flow | -24684000 |
|
| 2019 | Operating cash flow | -18728000 |
|
| 2020 | Operating cash flow | -93128000 |
|
| 2021 | Operating cash flow | -190434000 |
|
| 2022 | Operating cash flow | -319155000 |
|
| 2023 | Operating cash flow | -180147000 |
|
| 2024 | Operating cash flow | -28496000 |
|
| 2025 | Operating cash flow | 33279000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Free cash flow | -26867000 |
|
| 2019 | Free cash flow | -30651000 |
|
| 2020 | Free cash flow | -117222000 |
|
| 2021 | Free cash flow | -199834000 |
|
| 2022 | Free cash flow | -326311000 |
|
| 2023 | Free cash flow | -185397000 |
|
| 2024 | Free cash flow | -33987000 |
|
| 2025 | Free cash flow | 14262000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2019 | Liabilities / assets | 37% |
|
| 2020 | Liabilities / assets | 98.3% |
|
| 2021 | Liabilities / assets | 30% |
|
| 2022 | Liabilities / assets | 48.3% |
|
| 2023 | Liabilities / assets | 45.5% |
|
| 2024 | Liabilities / assets | 41.5% |
|
| 2025 | Liabilities / assets | 41.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2019 | Current assets / current liabilities | 4.08× |
|
| 2020 | Current assets / current liabilities | 2.37× |
|
| 2021 | Current assets / current liabilities | 4.77× |
|
| 2022 | Current assets / current liabilities | 1.47× |
|
| 2023 | Current assets / current liabilities | 3.1× |
|
| 2024 | Current assets / current liabilities | 3.61× |
|
| 2025 | Current assets / current liabilities | 2.46× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | −USD 23.9 million Exact valueExact value: -23900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24.68 million Exact valueExact value: -24684000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.18 million Exact valueExact value: 2183000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26.87 million Calculation and evidence-24684000 − 2183000 USD Exact free cash flow: -26867000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 29.7 million Exact valueExact value: -29704000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.73 million Exact valueExact value: -18728000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 11.92 million Exact valueExact value: 11923000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30.65 million Calculation and evidence-18728000 − 11923000 USD Exact free cash flow: -30651000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 241.34 million Exact valueExact value: -241340000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 93.13 million Exact valueExact value: -93128000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 24.09 million Exact valueExact value: 24094000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 117.22 million Calculation and evidence-93128000 − 24094000 USD Exact free cash flow: -117222000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 245.39 million Exact valueExact value: -245390000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 190.43 million Exact valueExact value: -190434000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 9.4 million Exact valueExact value: 9400000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 199.83 million Calculation and evidence-190434000 − 9400000 USD Exact free cash flow: -199834000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 548.98 million Exact valueExact value: -548980000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 319.16 million Exact valueExact value: -319155000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7.16 million Exact valueExact value: 7156000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 326.31 million Calculation and evidence-319155000 − 7156000 USD Exact free cash flow: -326311000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 175.77 million Exact valueExact value: -175767000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 180.15 million Exact valueExact value: -180147000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5.25 million Exact valueExact value: 5250000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 185.4 million Calculation and evidence-180147000 − 5250000 USD Exact free cash flow: -185397000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 52.29 million Exact valueExact value: -52286000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 28.5 million Exact valueExact value: -28496000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5.49 million Exact valueExact value: 5491000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 33.99 million Calculation and evidence-28496000 − 5491000 USD Exact free cash flow: -33987000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 21.02 million Exact valueExact value: -21021000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 33.28 million Exact valueExact value: 33279000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 19.02 million Exact valueExact value: 19017000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 14.26 million Calculation and evidence33279000 − 19017000 USD Exact free cash flow: 14262000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
35 filings · 3,746 latest values · 3,745 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001818331, 1818331, CMLF, WGS, edgar:1818331
Also known as CM LIFE SCIENCES, INC., CM Life Sciences, Inc., GeneDx Holdings Corp., Sema4 Holdings Corp.